AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger; Did Not Receive Votes

AMAG Pharmaceuticals, Inc. AMAG announced results from today's Special Meeting of AMAG Stockholders, at which a proposal to approve the issuance of shares of AMAG common stock to the stockholders of Allos Therapeutics, Inc. in connection with the merger with Allos did not receive the necessary votes to be adopted.